Summary Details

Stock Exchange Listing
Primary country listingUK
StatusAIM
IndexFTSE AIM All Share
SectorMedical Diagnostics & Research
Activities in the UK, US and Middle-EastANGLE PLC was incorporated on December 04, 2003 in England and Wales. It is a commercially driven specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company is commercializing a platform technology that can capture cells circulating in blood, such as cancer cells, even when it is rare in number as one cell in one billion blood cells, and harvest the cells for analysis. The Company has developed Parsortix cell separation device, which can capture rare circulating tumour cells (CTCs) in cancer patient blood.
EPICAGL
 
Overview from annual report:30/4/201530/4/2014
Ave. no. employees (excl. Dir.) 28 26
Gearing(%)-77.8-65.82
ROCE(%)-42.22-49.97
 
Latest results - Interim:31/10/201531/10/2014
Turnover(£m)00
Pretax profit(£m)-2.39-1.57
EPS (Norm Dil.)(p)-3.88-3.48
Dividend per share(p)00
NotesFigures from 2006 in accordance with IFRS
 
Figures at last close:
Closing share price(p)67.5
No. of shares in issue(m)58.97
Market capitalisation(£m)39.81

Investis

Share price data provided by vwd group & financial data provided by Morningstar.

 
Site map |  Email alerts |  Contact us |